BRCA1 and neoplasm: Consequently, oncologists speaking to individuals about tumor BRCA1/2 testing can do so in the context of therapeutic implications, with more detailed informed consent discussions around hereditary testing occurring at the time of genetic counseling following a positive tumor test.